BouncyBiscuit
Pharmeasy with a 90% cut in valuation
21mo ago
Talking product sense with Ridhi
9 min AI interview5 questions
GoofyCupcake
Stealth21mo
Major regulations coming in this market is what people are saying regarding why companies like pharmeasy are finding it difficult
SqueakyPickle
Google21mo
Pharmeasy has raised a total of $1.6 billion in funding till now.... And now valued at 500 millions $.... I hope VC who were bullish over India's decade have egg on their face now.
SparklyCoconut
UrbanPiper21mo
this is not a good thing, if vcs get egg on their face they wont invest in india anymore and thats bad for us, we will have to move out of india
FluffyMochi
Shell21mo
Its stock was being sold at 130 per share pre ipo.their stupid ceo paid so much fr thyrocare. N thyrocare founders sold n exited a competitive market.
SqueakyUnicorn
Stealth21mo
I know pharmeasy founders very well.
This is just a moment where everyone looks like a ghost but people who blame them for deep discounting to acquire customer will be proven wrong.
Because this is just 10% of their business, 90% comes from B2B with good margin.
BouncyBiscuit
Stealth21mo
On a 5000 Cr revenue it has a -2700 Cr loss and -2500 negative cash margins. What good margins are you on about? Current valuation takes their stock price at rs 9 from a peak of 135 in unlisted market. They took debt to buy a listed company thyrocare whose promoter probably laughed at the money they were giving him as he would never have got that valuation in the listed space. Now they are raising funds aat this valuation to pay off that stupid debt they took for the aquisition.
SwirlyNoodle
Stealth21mo
Rights issue at lower price doesn't mean valuation has reduced. Check last rights issue price of Voda-Idea, Airtel and several others. Rights issues are generally done when company is unable to raise money at a high valuation from new investors but existing investors are willing to contribute. Lower price forces existing disinterested investors to participate, else make peace with getting diluted.
Pharmeasy is easily a 2+ BN dollar company
PrancingPotato
Stealth21mo
🥲🥲
JazzyPancake
Stealth21mo
Serves em right for having 6 week days
FuzzyPickle
Stealth21mo
I have some Pre-IPO shares. 🤞:' )
FluffyMochi
Shell21mo
India is not a small market, but its a competitive market and businesses need to know how to sell to this value conscious audience. Not all users r fang devs who pay any money fr services not needed.
SqueakyPickle
Google21mo
Still overpriced
Discover more
Curated from across
by CosmicTacoGrapevine
PharmEasy's Valuation Plummets to $458 Million
- API Holdings, PharmEasy's parent company, now valued at $458 million, a 92% drop from its 2021 peak.
- Janus Henderson, a key investor, slashed its valuation by 91.8%, as per SEC filings.
- In April, PharmEasy faced a 90% valuation cut...
News Discussion10mo
by WigglyPotatoAnalyst
Indian Startups20mo
by QuirkyJellybeanProduct Manager
90% downround Pharmeasy
Horrific scenes in the Indian startup ecosystem. From being on the verge of an IPO to raising an emergency round which shall lead to the sudden death of employee ESOPs. Crores of wealth destroyed for the employees.
A chain reaction of h...
Top comment
CTC= fixed pay. That's your main course. Sometimes you get variable pay, that's dessert. Sometimes (more chance of an...